Adjuvant treatment with chemotherapeutic agents and polyadenylic-polyuridylic acid in operable stomach cancers. I. Enhancement of natural killer cell activity.
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011063:Poly A-U / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000601:surgery
D011063:Poly A-U; D004317:Doxorubicin; D005472:Fluorouracil